Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors
A cohort study of 11,575 patients with coronary artery disease
Jonathan Leor, MD, FACC*,
Henrietta Reicher-Reiss, MD, FACC ,
Uri Goldbourt, PhD ,
Valentina Boyko, MSc ,
Shmuel Gottlieb, MD ,
Alexander Battler, MD, FACC* and
Solomon Behar, MD
* Cardiology Department, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
Neufeld Cardiac Research Institute, Tel Aviv University, Tel Hashomer, Israel

View larger version (11K):
[in a new window]
|
Figure 1 Actuarial survival for patients treated with angiotensin-converting enzyme inhibitors with and without aspirin.
|
|

View larger version (12K):
[in a new window]
|
Figure 2 Actuarial survival for patients with heart failure (New York Heart Association class 2) treated with angiotensin-converting enzyme inhibitors with and without aspirin.
|
|
|